help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 27, 2002, doi:10.1164/rccm.200208-916OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200208-916OCv1
167/4/534    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holzer, K.
Right arrow Articles by Douglass, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holzer, K.
Right arrow Articles by Douglass, J.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 534-537, (2003)
© 2003 American Thoracic Society


Original Article

Mannitol as a Challenge Test to Identify Exercise-induced Bronchoconstriction in Elite Athletes

Karen Holzer, Sandra D. Anderson, Hak-Kim Chan and Jo Douglass

Department of Allergy, Asthma, and Clinical Immunology, Alfred Hospital and Monash University, Prahran, Victoria; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown; and Department of Pharmacy, University of Sydney, Sydney, New South Wales, Australia

Correspondence and requests for reprints should be addressed to Dr. Sandra Anderson, Ph.D., D.Sc., Department of Respiratory Medicine, E11S, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. E-mail: sandya{at}mail.med.usyd.edu.au

Bronchial provocation tests provide objective criteria for asthma and exercise-induced bronchoconstriction (EIB) and were recommended to justify the use of inhaled ß2-agonists by athletes at the Winter Olympics 2002. Eucapnic voluntary hyperpnea (EVH) was one test recommended to identify EIB. Provocation with EVH requires a special dry gas mixture limiting its availability. Provocation tests with osmotic aerosols require less expensive equipment that is easily portable. We assessed the sensitivity of a challenge with mannitol to identify responsiveness to EVH in 50 elite summer sport athletes who were unselected if they had respiratory symptoms. Asthma was previously diagnosed by a doctor in 27 subjects, and 21 subjects were currently under treatment for EIB or asthma. The mean predicted FEV1 was 103.6 ± 10.8%, FVC was 99 ± 13.3%, and mean forced expiratory flow during the middle half of the FVC was 104 ± 22.7%. A total of 25 subjects were positive to EVH challenge (mean percentage of fall in FEV1 was 25.4 ± 15% SD), and 26 subjects had a positive mannitol challenge (geometric mean [95% confidence interval] provoking dose causing a 10% fall in forced expiratory volume in one second [PD10] was 202 mg [134, 300], with 24 of the subjects positive to both challenges). Mannitol had a sensitivity of 96% and specificity of 92% to identify a positive response to EVH and, as such, could be used as an alternative to EVH to identify EIB.

Key Words: athletes • exercise • asthma • osmotic aerosol • hyperpnea




This article has been cited by other articles:


Home page
ThoraxHome page
K Holzer and J A Douglass
Exercise induced bronchoconstriction in elite athletes: measuring the fall
Thorax, February 1, 2006; 61(2): 94 - 96.
[Full Text] [PDF]


Home page
ChestHome page
J. P. Parsons and J. G. Mastronarde
Exercise-Induced Bronchoconstriction in Athletes
Chest, December 1, 2005; 128(6): 3966 - 3974.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. W. Rundell, S. D. Anderson, B. A. Spiering, and D. A. Judelson
Field Exercise vs Laboratory Eucapnic Voluntary Hyperventilation To Identify Airway Hyperresponsiveness in Elite Cold Weather Athletes
Chest, March 1, 2004; 125(3): 909 - 915.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J.D. Brannan, M. Gulliksson, S.D. Anderson, N. Chew, and M. Kumlin
Evidence of mast cell activation and leukotriene release after mannitol inhalation
Eur. Respir. J., September 1, 2003; 22(3): 491 - 496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  Registrer for the conference